Cargando…
Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3(2) Factorial Design to Improve Solubility and In Vitro Bioavailability
Piroxicam is a Biopharmaceutical Classification System (BCS) Class II drug having poor aqueous solubility and a short half-life. The rationale behind the present research was to develop a Piroxicam nanosuspension to enhance the solubility and thereby the in vitro bioavailability of the drug. Piroxic...
Autores principales: | Alhamhoom, Yahya, Honmane, Sandip M., Hani, Umme, Osmani, Riyaz Ali M., Kandasamy, Geetha, Vasudevan, Rajalakshimi, Paramshetti, Sharanya, R. Dudhal, Ravindra, K. Kengar, Namrata, Charde, Manoj S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919943/ https://www.ncbi.nlm.nih.gov/pubmed/36771784 http://dx.doi.org/10.3390/polym15030483 |
Ejemplares similares
-
Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules
por: Alhamhoom, Yahya, et al.
Publicado: (2022) -
Revolutionizing Drug Delivery and Therapeutics: The Biomedical Applications of Conductive Polymers and Composites-Based Systems
por: Paramshetti, Sharanya, et al.
Publicado: (2023) -
Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
por: Li, Haowen, et al.
Publicado: (2021) -
Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems – enhancement of oral bioavailability
por: Hashem, Fahima M, et al.
Publicado: (2015) -
COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study
por: Almaghaslah, Dalia, et al.
Publicado: (2021)